This study sought to assess whether low-dose aspirin benefits individuals with elevated plasma lipoprotein(a)-associated genotypes in the setting of primary prevention.

Editors

Editor-in-Chief
Valentin Fuster, MD, PhD, MACC

CME Editor
Ragavendra R. Baliga, MD

Authors
Harpreet S. Bhatia, MD
Paul Lacaze, PhD 
Sotirios Tsimikas, MD

Date of Release: September 26, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: September 25, 2023